3-nitropropionic acid has been researched along with mocetinostat in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Georgievska, B; Kaindlstorfer, C; Kugler, AR; Mather, RJ; Poewe, W; Sommer, P; Stefanova, N; Wenning, GK | 1 |
| Abdel Moneim, AE; Abdelfattah, MS; Aref, AM; Attia, GH; Badr, SEA; Kassab, RB; Lotfy, SA | 1 |
2 other study(ies) available for 3-nitropropionic acid and mocetinostat
| Article | Year |
|---|---|
Failure of Neuroprotection Despite Microglial Suppression by Delayed-Start Myeloperoxidase Inhibition in a Model of Advanced Multiple System Atrophy: Clinical Implications.
Topics: alpha-Synuclein; Animals; Brain; Disease Models, Animal; Enzyme Inhibitors; Humans; Male; Mice, Transgenic; Microglia; Motor Activity; Multiple System Atrophy; Myelin Proteolipid Protein; Neurons; Neuroprotective Agents; Nitro Compounds; Peroxidase; Propionates; Pyrimidinones; Pyrroles; Severity of Illness Index; Treatment Outcome | 2015 |
Rutin and Selenium Co-administration Reverse 3-Nitropropionic Acid-Induced Neurochemical and Molecular Impairments in a Mouse Model of Huntington's Disease.
Topics: Animals; bcl-2-Associated X Protein; Brain-Derived Neurotrophic Factor; Caspase 3; Catalase; Corpus Striatum; Down-Regulation; Drug Synergism; Glial Fibrillary Acidic Protein; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Huntington Disease; Interleukin-1beta; Male; Malondialdehyde; Mice; Neuroprotective Agents; Nitric Oxide; Nitro Compounds; Oxidative Stress; Peroxidase; Propionates; Proto-Oncogene Proteins c-bcl-2; Rutin; Selenium; Superoxide Dismutase; Synaptic Transmission; Tumor Necrosis Factor-alpha; Up-Regulation | 2020 |